What is semaglutide made out of, and why does it matter?

The decision most people don't realise they're making: natural vs synthetic hormone

When people ask what semaglutide is made out of, they're often trying to decide how comfortable they feel about taking it. Is it a chemical compound with no relation to human biology? Is it derived from animals? The honest answer is reassuring but a little more nuanced than a yes or no.

Semaglutide is a peptide (a short chain of amino acids) that mimics a hormone your intestines release naturally every time you eat. That hormone, GLP-1, signals to your brain that you've had enough food and tells your stomach to slow down. The natural version lasts only a couple of minutes before enzymes break it down. Semaglutide's designers kept 94% of that natural sequence and made targeted modifications to the remaining parts to stop those enzymes working on it so quickly.

One of those modifications attaches a fatty acid chain to the molecule. That chain binds loosely to albumin, a protein abundant in your blood, which acts as a kind of slow-release anchor. The result is a half-life of roughly a week, which is why a single injection covers seven days. This is covered in the NHS semaglutide medicines page, which gives a clear patient-level description of how the medicine works.

So semaglutide is not natural in the sense of being found in food or plants, and it is not synthetic in the sense of being entirely foreign to your biology. It sits in between: a carefully engineered version of something your own body already makes.

How semaglutide is actually manufactured, the biotech process

The manufacturing story is worth knowing because it shapes what the medicine is, and isn't, made from. Semaglutide is produced using recombinant DNA technology. In practice, that means the genetic instructions for building the semaglutide peptide are inserted into yeast cells, a strain of Saccharomyces cerevisiae, the same species used in baking and brewing. Those cells are grown in large fermentation vessels and, as they multiply, they produce the peptide. It is then extracted, purified and modified with the fatty acid chain.

This approach means semaglutide is not derived from pigs, cows, or any other animal. It contains no gluten-derived ingredients in the final medicine. Novo Nordisk, who manufactures Wegovy, uses this fermentation route for semaglutide precisely because it allows consistent, scalable production of a complex molecule. If you want to read further into the manufacturing process, the detailed breakdown of how semaglutide is made covers the fermentation and purification steps.

The final injectable product, Wegovy, suspends the semaglutide peptide in a liquid solution inside a pre-filled pen. If you're curious about what Wegovy is made from, including the excipients that keep the molecule stable, the other ingredients in that solution include disodium phosphate dihydrate, propylene glycol, phenol and water for injections. None of the active effect comes from the excipients; they keep the molecule stable and safe for injection.

What the structure means for how it behaves in your body

Understanding the composition helps explain some practical things patients notice. Because semaglutide is a peptide, it cannot be absorbed through the gut wall in its standard injectable form, stomach acid and digestive enzymes would break it down before it reached the bloodstream. That's why the injection exists. The oral Wegovy tablet (approved by the MHRA in June 2026) pairs the semaglutide molecule with a special absorption enhancer called SNAC, which protects it across the stomach lining.

Once in the bloodstream, semaglutide binds to GLP-1 receptors in the brain's appetite centres and in the gastrointestinal tract. Gastric emptying slows, hunger signals quieten. It does not change your metabolism directly or burn fat through a thermogenic effect; the weight loss comes from eating less, more easily. A quick thing to check if you're curious about the clinical evidence: the STEP 1 trial, published in the New England Journal of Medicine, remains the reference point for what the 2.4mg weekly injection produced in a large randomised study, roughly 15% average body-weight reduction over 68 weeks.

Because the molecule resembles a natural hormone rather than a foreign chemical, the body's receptors recognise and respond to it. That familiarity also explains the side-effect profile: most are gastrointestinal (nausea, loose stools, slowed digestion) because those are the systems GLP-1 naturally influences. They tend to settle once the body adjusts.

What this means if you're weighing up whether to start

Knowing the composition doesn't tell you whether semaglutide is right for you specifically, that requires a clinical conversation. But it does help frame the decision honestly. Wegovy is a biotechnology-derived prescription medicine, built from a modified version of a human hormone, manufactured through a fermentation process with no animal-derived active ingredients. It has a defined chemical structure, a well-characterised mechanism, and years of clinical trial data behind it.

If you'd like to understand how it compares with other options, our treatment overview covers the licensed weight-loss medicines available in the UK. Prescription eligibility depends on your BMI, any weight-related health conditions, and your full medical history, factors our prescribers work through with you. There's more background on what semaglutide is made from, including the biological origins of the molecule, in the history of who developed semaglutide. And if you're thinking about cost, our Wegovy page explains what private treatment includes.

When you're ready to find out whether it's clinically suitable for you, start your free consultation and a GPhC-registered prescriber will review your answers the same day.